These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 975080)

  • 1. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
    Deodhar SD; Lee VW; Chiang T; Mahmoud AF; Watten KS
    Cancer Res; 1976 Sep; 36(9 pt.1):3147-50. PubMed ID: 975080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems.
    Kumar MS; Chiang T; Deodhar SD
    Cancer Res; 1979 Sep; 39(9):3515-8. PubMed ID: 476677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cadmium exposure on primary tumor growth and cell-mediated cytotoxicity in mice bearing MSB sarcomas.
    Kerkvliet NI; Koller LD; Baecher LG; Brauner JA
    J Natl Cancer Inst; 1979 Aug; 63(2):479-83. PubMed ID: 287837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Vinblastine on antitumour immunity in mice.
    Klener P; Bubeník J; Jandejsek J
    Neoplasma; 1973; 20(3):239-42. PubMed ID: 4725513
    [No Abstract]   [Full Text] [Related]  

  • 9. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioassay for quantitating circulating tumor cells in a syngeneic mouse tumor system.
    Lee VW; Chiang T; Deodhar SD
    Cancer Res; 1976 Jun; 36(6):2053-8. PubMed ID: 1268858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors.
    Ishida T; Oyama T; Carbone DP; Gabrilovich DI
    J Immunol; 1998 Nov; 161(9):4842-51. PubMed ID: 9794417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T; Shishido K; Murata K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K; Chang AE; Shu SY
    Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of allogeneic sarcoma in mice subjected to halothane anesthesia and/or surgical stress.
    Radosević-Stasić B; Udović-Sirola M; Stojanov L; Ribarić L; Rukavina D
    Anesth Analg; 1989 Nov; 69(5):570-4. PubMed ID: 2802192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some data concerning immune processes in concomitant tumor immunity experimental models. Comparative in vivo and in vitro investigation I. In vivo experiments.
    Badea E; Donovan G; Dumitrescu R; Fadel L; Popp I
    Neoplasma; 1977; 24(3):295-301. PubMed ID: 895939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.